Details of USPlabs LLC’s responsesto FDA’s warnings and order to cease marketing DMAA could help shield the firm from potential lawsuits and state or federal investigations.
“Surrendering without making any admissions about having violated the law can lessen the possibility of a more vigorous regulatory investigation of the past conduct, such as by FDA’s Office of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?